N-HYDROXYFORMAMIDDERIVAT UND ARZNEIMITTEL DAMIT

European patent · EP2597084 · Deleted

Register entry

Publication number
EP2597084
Application number
EP11803563
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 5, 2011
Published
May 29, 2013
Granted
Jun 29, 2016
Deleted
Jul 31, 2020
Reason
Annual fee unpaid
IPC classes
C07C 317/40 (2006.01)
A61K 31/16 (2006.01)
A61K 31/5375 (2006.01)
A61P 1/02 (2006.01)
A61P 1/04 (2006.01)
A61P 11/06 (2006.01)
A61P 17/00 (2006.01)
A61P 17/04 (2006.01)
A61P 17/06 (2006.01)
A61P 19/02 (2006.01)
A61P 25/00 (2006.01)
A61P 31/00 (2006.01)
A61P 31/04 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
A61P 43/00 (2006.01)
C07D 295/12 (2006.01)
Priority
JP 2010156025 08.07.2010
PCT application
PCT/JP2011/065317 05.07.2011
PCT publication
WO2012/005229 12.01.2012
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 17, 2021

    Deleted, fee unpaid

    Published in Swissreg on 17.02.2021

  2. Jun 29, 2016

    Granted

    Published in Swissreg on 29.06.2016

Parties

Holder

Kaken Pharmaceutical Co., Ltd.

28-8, Honkomagome 2-chome Bunkyo-ku, Tokyo 113-8650, JP

Inventor

KAWAI Kentaro

Kyoto-shi Kyoto 607-8042, JP

MIYAMOTO Shigeru

Kyoto-shi Kyoto 607-8042, JP

SHIMANO Masanao

Kyoto-shi Kyoto 607-8042, JP

HAINO Makoto

Tokyo 113-8650, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.